Groundbreaking US partnership aims to advance IVF treatment

A US fertility company announces a new partnership to bring automation and digital tracking into its IVF laboratories. 

The American fertility provider, CCRM Fertility, will expand its partnership with the world’s first automated platform for the management and care of the frozen eggs and embryos used in IVF.

The new technology created by the company TMRW Life Sciences aims to reduce the risk of losing or misidentifying the eggs and embryos used in IVF.

CCRM Fertility will extend the partnership with TMRW in all its IVF laboratories across North America, hoping to bring digital tracking, automation and 24/7 remote monitoring to a system that has long relied on manual, in-person work by embryologists.

The management platform will enable the clinical teams to identify, track and monitor patient specimens with a higher level of safety, efficiency and transparency.

The technology aims to reduce risk of mix-ups or lost eggs and embryos, give access to real-time data about frozen eggs and embryos and allow long-term security and traceability of eggs and embryos before, during and after IVF.

“As an early adopter of TMRW’s technology in our Colorado lab, we know firsthand what a difference TMRW’s platform will make to our clinics and everyone we serve,” says Jason Swain, PhD, who oversees the CCRM Fertility network of labs.

“The platform allows our embryologists to focus on the work that only they can do. TMRW provides peace of mind to our team and raises the standard of care for our patients.”

Tara Comonte, CEO of TMRW, adds: “In a process as deeply personal as fertility treatment, patients increasingly strive for a deep understanding of what’s happening every step of the way. They want to know their eggs and embryos are safe.

“Our growing partnership with CCRM Fertility will provide patients greater visibility, connection and accuracy, and ensure they receive the care they deserve.”